0001615186-16-000006.txt : 20160811
0001615186-16-000006.hdr.sgml : 20160811
20160811183610
ACCESSION NUMBER: 0001615186-16-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160811
FILED AS OF DATE: 20160811
DATE AS OF CHANGE: 20160811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCall Thomas D
CENTRAL INDEX KEY: 0001615186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 161825811
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-08-11
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001615186
McCall Thomas D
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Vice President and Gen'l Mgr.
Common Stock
2016-08-11
4
X
0
1700.0
43.12
A
2129
D
Common Stock
2016-08-11
4
S
0
1700.0
126.0314
D
429
D
Common Stock
2016-08-11
4
S
0
371.0
126.2612
D
58
D
Non-Qualified Stock Option (right to buy)
43.12
2016-08-11
4
X
0
1700.0
43.12
D
2015-02-02
2021-02-02
Common Stock
1700
300
D
The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.98 to $126.08, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
These securities are Restricted Stock Units.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire For: Thomas D. McCall
2016-08-11